Over 65,000 women in the US will be diagnosed with uterine cancer, every year. Most women are evaluated for uterine cancer only after irregular bleeding occurs (such as with post-menopausal women) or bleeding between periods (for younger women).

Lab-only testing has shown great promise.

Clinical testing needs to be done. Based on highly accurate lab-only testing, there is great potential for Early Detection’s EarlyTest to become the first uterine cancer screening test.

The lab-only testing identified 91 percent of uterine cancers and had no false positives with healthy controls. The data was published in the highly regarded medical journal: Cancer Research.

This test can easily be performed as part of a physical exam.

To conduct the test, a second cervical sample can be obtained at the same time as a pap smear is performed, which will take less than one minute. Similar to how sugars produced anywhere in the colon can be found at the rectum, sugars from uterine cells can be found at the cervix, which is the opening of the uterus.

Pap smears check for cervical cancer.

Pap smears evaluate for cervical cancer, not uterine cancer. Occasionally, uterine cancer cells are found while conducting a pap smear. Unfortunately, this is uncommon. If uterine clinical testing for the altered sugar has anywhere near the accuracy as shown in the lab tests, then pap smears could be used to collect a second swab to then check for both cervical and uterine cancers.